Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878

A discrete DEP device for the separation of malaria-infected cells.

Panklang N. et al, (2022), Electrophoresis

Assessment In Vitro of the Antimalarial and Transmission-Blocking Activities of Cipargamin and Ganaplacide in Artemisinin-Resistant Plasmodium falciparum.

Yipsirimetee A. et al, (2022), Antimicrobial agents and chemotherapy, 66

Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester

Harrington WE. et al, (2021), BMC Medicine, 19

Returned traveler presenting with anemia: Clinical challenge of post-artesunate delayed hemolysis.

Matsee W. et al, (2021), Journal of travel medicine

Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage.

Kümpornsin K. et al, (2021), International journal for parasitology. Drugs and drug resistance, 17, 186 - 190

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure.

Witmer K. et al, (2020), Antimicrobial agents and chemotherapy, 65

Vivax malaria in pregnancy and lactation: a long way to health equity

Brummaier T. et al, (2020), Malaria Journal, 19

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)

Schilling WHK. et al, (2020), Wellcome Open Research, 5, 241 - 241

Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis.

Imad HA. et al, (2020), The American journal of tropical medicine and hygiene, 102, 943 - 950

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360

Artemisinin-resistant malaria parasites show enhanced transmission to mosquitoes under drug pressure

Witmer K. et al, (2020)

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

von Seidlein L. et al, (2020), Human Vaccines & Immunotherapeutics, 16, 33 - 41

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

van der Pluijm RW. et al, (2019), The Lancet Infectious Diseases, 19, 952 - 961

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.

Hanboonkunupakarn B. et al, (2019), Antimicrobial agents and chemotherapy, 63

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal.

Rijal KR. et al, (2019), The Journal of infectious diseases, 220, 448 - 456

Enumeration of the Invasion Efficiency of Plasmodium falciparum In Vitro in Four Different Red Blood Cell Populations Using a Three-Color Flow Cytometry-Based Method.

Vimonpatranon S. et al, (2019), Cytometry. Part A : the journal of the International Society for Analytical Cytology, 95, 737 - 745

Identifying the Components of Acidosis in Patients With Severe Plasmodium falciparum Malaria Using Metabolomics

Leopold SJ. et al, (2019), The Journal of Infectious Diseases, 219, 1766 - 1776

Load More

1
2
3
4
5

Include forthcoming?